Six-month humoral and cellular immune response to the third dose of BNT162b2 anti-SARS-CoV-2 vaccine in patients with solid tumors: a longitudinal cohort study with a focus on the variants of concern
-
Published:2022-10
Issue:5
Volume:7
Page:100574
-
ISSN:2059-7029
-
Container-title:ESMO Open
-
language:en
-
Short-container-title:ESMO Open
Author:
Lasagna A.ORCID,
Bergami F.,
Lilleri D.,
Percivalle E.,
Quaccini M.,
Serra F.,
Comolli G.,
Sarasini A.,
Sammartino J.C.,
Ferrari A.,
Arena F.,
Secondino S.,
Cicognini D.,
Schiavo R.,
Lo Cascio G.,
Cavanna L.,
Baldanti F.,
Pedrazzoli P.,
Cassaniti I.
Subject
Cancer Research,Oncology
Cited by
12 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献